WOBURN, Mass., Nov. 01, 2016 -- Metabolix, Inc. (NASDAQ:MBLX), announced today that the Company plans to release its third quarter 2016 financial results and host a conference call with management after market close on Wednesday, November 9, 2016.
While shareholders participate in the call in listen-only mode, the Company invites shareholders to submit questions by November 7, 2016 for consideration to [email protected] with the subject line: “Questions for Third Quarter Call.” Questions submitted in advance of the call will be reviewed and a certain number of them may be addressed in management's prepared remarks or in the Q&A portion of the call.
Interested participants can join the conference call using the following numbers:
U.S. Toll-free dial-in: 1-877-709-8150
International dial-in: 201-689-8354
Event Date/Time: Wednesday, Nov. 9 at 4:30 p.m. ET
A live webcast of the call including the slide deck can be accessed through the investor relations section of the Company’s website at www.metabolix.com. In addition, the webcast will be archived on the Company’s website in the investor relations section.
To listen to a telephonic replay of the conference call, dial toll-free 877-660-6853 or 201-612-7415 (international) and enter pass code 13648037. The replay will be available for 14 days.
About Metabolix
Metabolix, Inc. is winding down its legacy PHA biopolymer business and becoming Yield10 Bioscience. Yield10 is leveraging Metabolix’s extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems with a focus on developing disruptive technologies for step-change improvements in crop yield. Yield10 is working on new approaches to improve fundamental elements of plant metabolism through enhanced photosynthetic efficiency and directed carbon utilization. Yield10 is advancing the development of several yield traits in crops such as camelina, canola, soybean and corn. The Company is based in Woburn, MA.
For more information, visit www.metabolix.com. (MBLX-E)
For more information on Yield10 Bioscience, visit Yield10.
Metabolix Contact: Lynne H. Brum, 617-682-4693, [email protected]


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



